# Megafine Pharma (P) Limited – FDA Inspection, Mar 6, 2020

Source: https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/d31b8c30-3b1a-4524-8262-69f74885e8e4
Source feed: FDA_Inspections

> FDA inspection 1122874 of Megafine Pharma (P) Limited, March 06, 2020. Classification: Official Action Indicated (OAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1122874
- Company Name: Megafine Pharma (P) Limited
- Inspection Date: 2020-03-06
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1195646 - 2023-01-24](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/5d607a40-9c0f-4492-9ad3-5f8e69123f40)
- [FDA Inspection 1054711 - 2018-05-12](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/ad44a079-acf0-43f8-84fb-ef3cf6fef858)
- [FDA Inspection 929021 - 2015-05-15](https://www.keypedia.com/records/fda_inspections/megafine-pharma-p-limited/d0300afa-481e-4cf8-8dda-04e5a7d2cfc7)
- FDA Inspection 730085 - 2011-06-02

Company: https://www.keypedia.com/companies/megafine-pharma-p-limited/da2f1945-a6c8-4238-ad26-92b889339f04

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
